2019-08-01

Cadence Health Completes Series B Financing

Receives $1 Million Donation from Templeton World Charities

Nathalie Molina Niño elected to the Board of Directors

article heroarticle hero

OAKLAND, Calif. – August 1, 2019 – Cadence Health, a mission-driven organization focused on women’s health OTC products, today announced the successful closing of its $13 million Series B financing including a $4.7 million convertible note. Social impact funds and family offices participated in the financing, with Templeton World Charities donating $1 million.

“We are thrilled to welcome several new mission-aligned investors who are passionate about our pursuit to bring the birth control pill over the counter, making it accessible for all women,” said Samantha Miller, Chief Operating Officer and co-Founder of Cadence Health. “We sincerely appreciate Templeton’s vote of confidence in our strategic plan and team, and we look forward to putting this capital to work immediately.”

In conjunction with the financing, Nathalie Molina Niño, president of O³ and an advisor to the company, will join the board of directors. The addition of Ms. Molina Niño brings the total number of board members to five.

Dr. Hosang continued, “We have been working with Nathalie for the last two years, and believe her knowledge, her commitment to women and their empowerment, and her deep connections within the women’s health community will be vital to our success as we bring the pill over the counter.”

“Cadence has all of the important pieces to enable women to make their own reproductive health decisions – the products, the people and the passion,” said Ms. Molina Niño. “I believe in their power to not only launch the birth control pill over-the-counter but also to build an efficient women’s health organization dedicated to better and empowered healthcare.”

Nathalie is an investor (managing director at Known Holdings), global tech entrepreneur, and champion of women and the planet. She is the author of LEAPFROG, The New Revolution for Women Entrepreneurs (Penguin Random House, Tarcher Perigee) and serves as a Venture Partner at Connectivity Capital Partners. Nathalie launched her first tech startup at the age of twenty and is the co-founder of Entrepreneurs@Athena at the Athena Center for Leadership Studies of Barnard College at Columbia University. She also founded O³, BRAVA Investments, and served as CRO of PowerToFly, the fastest growing hiring platform for women in tech. She has advised organizations such as Disney, Microsoft, MTV, Mattel and the Bill & Melinda Gates Foundation. Currently she serves as an advisor for the WOCstar Fund, FullCycle, Accion Opportunity Fund and serves on the advisory board of Vote Run Lead, WE NYC (Women Entrepreneurs NYC) and the The American Medical Association's Center for Health Equity and is on the board of National Institute for Reproductive Health. In 2019, she was honored with Schneps’ inaugural Women of Wall Street Awards for her influence in banking and finance and was named among People Magazine’s most powerful Latinas.

About Cadence Health

Cadence Health is knocking down the obstacles between women and the reproductive health options they want – starting with bringing The Pill over the counter. We’re making safe, affordable options available to all women, without a prescription. Based in Oakland, California, Cadence is founded, led, and supported by a diverse team of internationally renowned reproductive health experts, world-class entrepreneurs, and champions of women. A public benefits company, Cadence is committed to transforming reproductive health for all women everywhere.

Additional Articles

2020-09-01

Cadence Health Completes Series C Financing to Advance Over-the-Counter Switch for an Oral Birth Control Pill

Read More
article clip

2020-07-01

Cadence Health Completes Pivotal Studies of Zena™ in Effort to Bring Approved Oral Birth Control Pill Over-the-Counter

Read More
article clip

2020-07-01

Cadence Health Strengthens Management Team

Read More
article clip